BANGALORE, India & HYDERABAD, India, January 06, 2026--(BUSINESS WIRE)--Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable ...
BENGALURU, India & SAN CARLOS, Calif.--(BUSINESS WIRE)--Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with operations in India and the United States, ...
Biotech firm Pandorum Technologies announced on Monday the closing of a $18 million in Series B financing round, led by Protons Corporate ...
https://www.thehindubusinessline.com/companies/pandorum-technologies-nucelion-in-pact-for-tissue-regenerative-therapy-for-ocular-diseases/article70477136.ece Copy ...
Pharma Funding Roundup: QuantX Biosciences, Pandorum Technologies Complete Series B Financing Rounds
QuantX will deploy Series B proceeds toward IND-enabling advancement of oral STAT6 and IL-17 inhibitors in immunology/inflammation and continued discovery expansion on its computational platform.
Pandorum Technologies and Nucelion Therapeutics Announce Strategic Collaboration to Manufacture Exosome-Based Tissue Regenerative Therapy for Ocular Diseases in APAC Markets Pandorum Technologies, a ...
Funding accelerates clinical development and market access across the U.S., Asia, and the Middle East Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with ...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue regeneration, today announced a strategic collaboration with Hyderabad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results